To take full advantage of the microenvironment provided by brain explants, we chose a syngeneic murine glioma model based on transduction of Ink4a/Arf–null neural stem/progenitor cells with the oncogene H‐RasV12. This evidence concerns the gene CDKN2A and central nervous system cancer.